Coombs, C. C., Woyach, J. A., Brown, J. R., Ghia, P., Roeker, L. E., Patel, K., Eyre, T. A., Tam, C. S., Seymour, J. F., Shah, N. N., Flinn, I. W., Cheah, C. Y., Ma, S., Rhodes, J. M., Izutsu, K., Jurczak, W., Wierda, W. G., Loubert, A., Payakachat, N., … Lamanna, N. (2023). Patient-Reported Outcomes (PROs) Among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Pirtobrutinib: Analysis from the BRUIN Phase 1/2 Study. Blood, 142(Supplement 1), 6535–6535. https://doi.org/10.1182/blood-2023-186145
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
(OpenAlex Topic)
Efficacy and Resistance in CML Treatment
(OpenAlex Topic)
Lymphoid Neoplasms
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/blood-2023-186145
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: